MarketPulse
A

$ALKS

2 articles found
1 positive
0 negative
1 neutral
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Fund Liquidates $69M Viridian Position Despite 75% Annual Rally

Commodore Capital liquidates its entire $69M Viridian position despite the stock's 75% annual rally, signaling strategic reallocation ahead of anticipated FDA decisions.
VRDNALKSTYRAbiotech portfolio exitposition liquidation
The Motley FoolThe Motley Fool··Jonathan Ponciano

Commodore Capital Expands Spyre Therapeutics Position as Stock Climbs 63% YoY

Commodore Capital increases Spyre Therapeutics stake to $78.24M as stock surges 63% YoY. Biotech firm has $757M cash and expects Phase 2 data in 2026.
ALKSSYRERLAYXENEbiotechbalance sheet strength